Esin Merve Erol Koç

Esin Merve Erol Koç


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
PDF file
EKEsin Merve Erol Koç
Esin Merve Erol Koç
RFRahime Bedir Fındık
Rahime Bedir Fındık
HAHatice Akkaya
Hatice Akkaya
IKIşılay Karadağ
Işılay Karadağ
ETEda Özden Tokalıoğlu
Eda Özden Tokalıoğlu
ÖTÖzlem Moraloğlu Tekin
Özlem Moraloğlu Tekin
Objectives: To evaluate the relationship between Coronavirus Disease 2019 (COVID-19) in pregnancy and adverse perinatal outcomes. The secondary aim is to analyze the diagnostic value of hematologic parameters in COVID-19 complicated pregnancies. Methods: The current study is conducted in a high volume tertiary obstetrics center burdened by COVID-19 pandemics, in Turkey. In this cohort study, perinatal outcomes and complete blood count indices performed at the time of admission of 39 pregnancies (Study group) complicated by COVID-19 were compared with 69 uncomplicated pregnancies (Control group). Results: There was no significant difference between the obstetric and neonatal outcomes of pregnancies with COVID-19 compared to data of healthy pregnancies, except the increased C-section rate (p=0.026). Monocyte count, red cell distribution width (RDW), neutrophil/lymphocyte ratio (NLR), and monocyte/lymphocyte ratio (MLR) were significantly increased (p<0.0001, p=0.009, p=0.043, p<0.0001, respectively) whereas the MPV and plateletcrit were significantly decreased (p=0.001, p=0.008) in pregnants with COVID-19. ROC analysis revealed that the optimal cut-off value for MLR was 0.354 which indicated 96.7% specificity and 59.5% sensitivity in diagnosis of pregnant women with COVID-19. A strong positive correlation was found between the MLR and the presence of cough symptom (r=41.4, p=<0.0001). Conclusions: The study revealed that, pregnancies complicated by COVID-19 is not related with adverse perinatal outcomes. MLR may serve as a supportive diagnostic parameter together with the Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) in assessment of COVID-19 in pregnant cohort.

1 January 2024 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
EOEda Ureyen Ozdemir
Eda Ureyen Ozdemir
GBGul Nihal Buyuk
Gul Nihal Buyuk
EKEsin Merve Erol Koç
Esin Merve Erol Koç
GIGoksun Ipek
Goksun Ipek
UOUlku Gurbuz Ozbebek
Ulku Gurbuz Ozbebek
NHNecati Hancerliogullari
Necati Hancerliogullari
Ureyen Ozdemir E, et al. Yonsei Med J. 2024 May;65:e29. https://doi.org/10.3349/ymj.2023.0334

22 January 2022 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
BKBugra Bilge Keseroglu
Bugra Bilge Keseroglu
OAOsman Aydın
Osman Aydın
EKEsin Merve Erol Koç
Esin Merve Erol Koç
VBVeysel Bayburtluoglu
Veysel Bayburtluoglu
CYCem Nedim Yuceturk
Cem Nedim Yuceturk
KAKoray Agras
Koray Agras

18 July 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
EKEsin Merve Erol Koç
Esin Merve Erol Koç
HÇHatice Kansu Çelik
Hatice Kansu Çelik
DSDilek Sahin
Dilek Sahin
Intrauterine Growth Restriction (IUGR) is the inability of the fetus to achieve the biologically accessible growth potential. Irisin is a recently discovered adipomyokine with a crucial role in ene...

5 February 2025 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
MTMerve Didem Eşkin Tanrıverdi
Merve Didem Eşkin Tanrıverdi
ESEcem Kaya Sezginer
Ecem Kaya Sezginer
EKEsin Merve Erol Koç
Esin Merve Erol Koç
ÖTÖzlem Moraloğlu Tekin
Özlem Moraloğlu Tekin

22 October 2021 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
EKEsin Merve Erol Koç
Esin Merve Erol Koç
HAH. Akkaya
H. Akkaya
MOM. G. Ozaksit
M. G. Ozaksit
OTO. Moraloglu Tekin
O. Moraloglu Tekin